EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
instr__news
Novavax (NASDAQ:NVAX) Stock Price Up 3.8% - Time to Buy?
Novavax, Inc. (NVAX): Among Unstoppable Stocks That Could Double Your Money
Novavax (NASDAQ:NVAX) Trading Up 3.8% - Should You Buy?
Novavax (NVAX) Faces Uncertainty Amidst FDA Approval Delay
FDA Delays Full Approval of Novavax COVID Vaccine | Newsmax.com
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Analysts
FDA Delays Final Approval of Novavax COVID Vaccine - Drugs.com MedNews
Novavax (NVAX) Stock Climbs Amid FDA Approval Delay for COVID-19 Vaccine
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance | CNN
Novavax (NVAX) COVID-19 Vaccine Approval Delayed by FDA
News Highlights: Top Company News of the Day - Wednesday at 3 PM ET | Morningstar
Novavax Hasn't Gotten FDA Decision on Covid Vaccine BLA
FDA Delays Novavax Covid-19 Vaccine Approval, Requests Additional Data
Novavax (NasdaqGS:NVAX) Sees 21% Weekly Drop As Leadership Changes Shake Market
Health Care Up on Defensive Rotation - Health Care Roundup | Morningstar
Novavax (NASDAQ:NVAX) Shares Gap Down - Here's Why
Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now
Swiss National Bank Boosts Stake in Novavax, Inc. (NASDAQ:NVAX)
Zacks Research Comments on Novavax FY2027 Earnings
Novavax (NASDAQ:NVAX) Stock Price Down 6.1% - Here's Why
Novavax, Inc. (NASDAQ:NVAX) Receives $18.00 Average Price Target from Brokerages
Novavax call volume above normal and directionally bullish | Markets Insider
Novavax announces Young to retire as Chair of the Board, McGlynn to succeed | Markets Insider
Novavax Names Margaret McGlynn Board Chair, Replacing Young
Novavax Appoints Margaret McGlynn To Succeed James Young As Chair Of The Board
Latest news
Stock Market Today: Dow, S&P 500 Drop, Nasdaq Rises in Volatile Session
Morning Note: Trade Fears Hit Nvidia, Deepen US-China Clash; UK Seeks US Deal
